Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

70.8K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.8K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

15
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
15
Acute Pharyngitis01:30

Acute Pharyngitis

792
Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
792
Pneumonia IV: Management01:28

Pneumonia IV: Management

353
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
353
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

435
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
435
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

35
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
35

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Isolation and characterization of mesenchymal stem cells from caprine umbilical cord tissue matrix.

Tissue & cell·2016
Same author

Secretome Cues Modulate the Neurogenic Potential of Bone Marrow and Dental Stem Cells.

Molecular neurobiology·2016
Same author

Long-circulatory nanoparticles for gemcitabine delivery: Development and investigation of pharmacokinetics and in-vivo anticancer efficacy.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2016
Same author

Influence of immobilization and forced swim stress on the neurotoxicity of lambda-cyhalothrin in rats: Effect on brain biogenic amines and BBB permeability.

Neurotoxicology·2016
Same author

Isolation and characterization of alborixin from Streptomyces scabrisporus: A potent cytotoxic agent against human colon (HCT-116) cancer cells.

Chemico-biological interactions·2016
Same author

Pragmatic use of insulin degludec/insulin aspart co-formulation: A multinational consensus statement.

Indian journal of endocrinology and metabolism·2016

Related Experiment Video

Updated: Jul 16, 2025

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos
11:20

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos

Published on: May 12, 2020

6.6K

Phage therapy for Acinetobacter baumannii infection.

Ramneet Kaur1, Dibita Mandal2, Ajay Kumar3

  • 1Department of Basic and Applied Sciences, RIMT University, Punjab, India.

Progress in Molecular Biology and Translational Science
|September 22, 2023
PubMed
Summary

Acinetobacter bacteria exhibit significant antibiotic resistance, making infections difficult to treat. Phage therapy offers a promising alternative, targeting these resistant bacteria effectively with specific bacteriophages.

Keywords:
AcinetobacterBacteriophageCarbapenem resistantCombination therapyMultidrug resistantPhage therapy

More Related Videos

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
05:06

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Published on: January 5, 2024

640
Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases
07:47

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases

Published on: January 1, 2016

11.6K

Related Experiment Videos

Last Updated: Jul 16, 2025

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos
11:20

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos

Published on: May 12, 2020

6.6K
Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
05:06

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Published on: January 5, 2024

640
Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases
07:47

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases

Published on: January 1, 2016

11.6K

Area of Science:

  • Microbiology
  • Bacteriology
  • Infectious Diseases

Background:

  • Acinetobacter is a gram-negative nosocomial pathogen known for its high levels of antibiotic resistance.
  • The increasing prevalence of multidrug-resistant Acinetobacter complicates treatment strategies for hospital-acquired infections.

Purpose of the Study:

  • To review recent advancements in phage therapy as a viable treatment option against Acinetobacter infections.
  • To explore the mechanisms and effectiveness of various bacteriophages and their components in combating antibiotic-resistant Acinetobacter.

Main Methods:

  • Elaboration on various phage therapy approaches currently in use.
  • Discussion of phage propagation methods and resistance mechanisms.
  • Analysis of specific bacteriophages including Acibel004, Acibel007, vB-GEC_Ab-M-G7, ZZ1, and Bacteriophage p54 with Endolysin LysAB54.

Main Results:

  • Phage therapy demonstrates efficacy against carbapenem-resistant Acinetobacter strains.
  • Specific bacteriophages and endolysins show potential for targeted bacterial infection treatment.
  • Understanding phage propagation and resistance is crucial for therapeutic success.

Conclusions:

  • Phage therapy presents a potent strategy to overcome antibiotic resistance in Acinetobacter infections.
  • The use of specific bacteriophages and their lytic enzymes offers a promising avenue for novel antimicrobial treatments.
  • Further research into phage-host interactions and resistance is essential for clinical application.